as variable of high disease activity state showed the following: for ASDAS-CRP, ASDAS-ESR and BASDAI the AUCs (area under curve) were 0.89 (P=0.05; 95% CI 0.80-0.99), 0.88 (P<0.001; 95% CI 0.77-0.99), and 0.99 (P=0.009; 95% CI 0.97-1.00).For CRP and ESR the AUCs were 0.81 and 0.79. This shows the high accuracy of the three scores in assessing SpA activity,but with a lower fidelity of the inflammatory markers alone.When dividing patients according to BASDAI score,14% showed a more active disease than the rest of 86% who had low disease activity.Mean ASDAS-CRP scores in the first group was 3.31.When correlating disease activity scores for the entire study group we observed that BASDAI correlated to both ASDAS scores (r=0.65 and 0.71, P<0.001) and that PtGA showed a stronger correlation to BASDAI (r=0.912, P<0.01) than ASDAS and to acute phase reactants. Conclusions: This study shows that disease activity scores have good discriminatory powers. BASDAI surpassed ASDAS scores when relating to the PtGA. According to Van der Heijde et al.(1), the only situation in which BASDAI can outperform ASDAS is when assessing the PASS (patient acceptable symptom state). However, ASDAS-CRP had better discriminatory power than ASDAS-ESR or acute phase reactants. This demonstrates that ASDAS-CRP is a more objective evaluation that can better differentiate patients with high or low disease activity.
THU0666 PATIENT GLOBAL ASSESSMENT IS MORE SENSITIVE TO CHANGE THAN HEALTH-RELATED QUALITY OF LIFE INSTRUMENTS IN EARLY AXIAL SPONDYLOARTHRITIS OVER 3 YEARS: DATA FROM THE DESIR COHORT
Objectives: To evaluate sensitivity to change (ie, discriminance) of several questionnaires in early axial spondyloarthritis (axSpA) over 3 years of follow up: the SF36, axial spondyloarthritis quality of life (ASQoL), axial spondyloarthritis health assessment questionnaire (AS-HAQ) and patient global assessment (PGA). Methods: DESIR is an ongoing prospective, multicenter, longitudinal, observational French cohort (1). Patients had inflammatory back pain of more than 3 months and less than 3 years suggestive of axSpA. For our analysis, only patients with no missing data for MCS and PCS SF36 values during the first 3 years were included. A global construct of patient global state was assessed by the SF36 questionnaire and its 2 subscales (scored 0-100 with higher scores indicating better status): the physical composite score (PCS) and the mental composite score (MCS), AsQoL, a disease-specific HRQoL scale, PGA and AS-HAQ. ASDAS-CRP was used as comparator. Each outcome was assessed at baseline, 6 months, 12 months, 24 months and 36 months. Standardized mean differences (SMD) were calculated using Cohen's effect size with confidence intervals, between each time point for each outcome. A SMD <0.5 is usually considered small, between 0.5 and 0.8 moderate and >0.8 as important. Results: In all, 442 patients were analyzed: at baseline, mean age was 34.2±8.6 years; mean disease duration was 18.6±10.7 months; 239 (54%) were females, 274 (62%) had HLAB27 and 124 (28%) had radiological sacroiliitis. At baseline, patients were not in an optimal state; improvement was clear up to month 6 then minimal (at the group level): Table. Sensitivity to change was greatest for PGA, then ASQoL whereas AS-HAQ, MCS and PCS appeared the least discriminant measure (Table) 
